TRACON Pharmaceuticals, Inc. Deferred Revenue Recognized
TRACON Pharmaceuticals, Inc. reported Deferred Revenue Recognized of $3.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2019-03-01
- TRACON Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was $3.00M.
- TRACON Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2018 was $3.00M.
- TRACON Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2017 was $0.00.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|
| 2018-12-31 | $3.00M 10-K · filed 2019-03-01 | |
| 2018-03-31 | $3.00M 10-K · filed 2019-03-01 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |